| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1312635 | 6480464 | Ethinyl Estradiol affects the expression of ASF1B mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1312635 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASF1B mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1312635 | 6480464 | Ethinyl Estradiol results in increased expression of ASF1B mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1312635 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASF1B mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ASF1B mRNA | CTD | PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1312635 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ASF1B mRNA | CTD | PMID:21570461 |
| 3-methylcholanthrene | increases expression | ISO | RGD:1312635 | 6480464 | Methylcholanthrene results in increased expression of ASF1B mRNA | CTD | PMID:20713471 |
| 4-hydroxynon-2-enal | increases expression | ISO | RGD:1312635 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of ASF1B mRNA | CTD | PMID:19191707 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1312635 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of ASF1B mRNA | CTD | PMID:19191707 |
| aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of ASF1B protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | ISO | RGD:1312635 | 6480464 | Aflatoxin B1 results in increased expression of ASF1B mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of ASF1B mRNA | CTD | PMID:16249480 |
| arsenite(3-) | decreases expression | ISO | RGD:1312635 | 6480464 | arsenite results in decreased expression of ASF1B mRNA | CTD | PMID:18929588 |
| benzo[a]pyrene | increases expression | ISO | RGD:1312635 | 6480464 | Benzo(a)pyrene results in increased expression of ASF1B mRNA | CTD | PMID:20504355 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1312635 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of ASF1B mRNA | CTD | PMID:21715664 |
| bisphenol A | increases expression | ISO | RGD:1312635 | 6480464 | bisphenol A results in increased expression of ASF1B mRNA | CTD | PMID:20739668 |
| calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of ASF1B mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of ASF1B mRNA | CTD | PMID:21592394 |
| cefaloridine | increases expression | ISO | RGD:1304918 | 6480464 | Cephaloridine results in increased expression of ASF1B mRNA | CTD | PMID:18500788 |
| choline | multiple interactions | ISO | RGD:1312635 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ASF1B; more ... | CTD | PMID:20938992 |
| cisplatin | decreases expression | ISO | RGD:1304918 | 6480464 | Cisplatin results in decreased expression of ASF1B mRNA | CTD | PMID:22023808 |
| clofibrate | multiple interactions | ISO | RGD:1312635 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ASF1B mRNA; more ... | CTD | PMID:17585979 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of ASF1B mRNA | CTD | PMID:19320972 PMID:19376846 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ASF1B mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ASF1B mRNA | CTD | PMID:20971185 |
| coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of ASF1B mRNA | CTD | PMID:19167446 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of ASF1B mRNA; more ... | CTD | PMID:19167446 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ASF1B mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ASF1B mRNA | CTD | PMID:19159671 more ... |
| dasatinib (anhydrous) | decreases expression | EXP | | 6480464 | dasatinib results in decreased expression of ASF1B mRNA | CTD | PMID:20579391 |
| dibutyl phthalate | decreases expression | ISO | RGD:1312635 | 6480464 | Dibutyl Phthalate results in decreased expression of ASF1B mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:1312635 | 6480464 | Dibutyl Phthalate results in decreased expression of ASF1B mRNA | CTD | PMID:17361019 PMID:21266533 |
| diethyl maleate | increases expression | ISO | RGD:1304918 | 6480464 | diethyl maleate results in increased expression of ASF1B mRNA | CTD | PMID:21161181 |
| folic acid | multiple interactions | ISO | RGD:1312635 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ASF1B; more ... | CTD | PMID:20938992 |
| L-methionine | multiple interactions | ISO | RGD:1312635 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ASF1B mRNA; more ... | CTD | PMID:20938992 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1312635 | 6480464 | Diethylnitrosamine results in increased expression of ASF1B mRNA | CTD | PMID:17854601 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1312635 | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ASF1B mRNA] | CTD | PMID:17854601 |
| ozone | multiple interactions | ISO | RGD:1312635 | 6480464 | TTPA protein affects the reaction [Ozone results in increased expression of ASF1B mRNA] | CTD | PMID:19555225 |
| paracetamol | multiple interactions | ISO | RGD:1312635 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ASF1B mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ASF1B mRNA | CTD | PMID:22230336 |
| phenobarbital | multiple interactions | ISO | RGD:1312635 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ASF1B mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:1312635 | 6480464 | Phenobarbital results in increased expression of ASF1B mRNA | CTD | PMID:19482888 more ... |
| phenobarbital | increases expression | ISO | RGD:1312635 | 6480464 | Phenobarbital results in increased expression of ASF1B mRNA | CTD | PMID:19482888 PMID:20403969 |
| phenobarbital | increases expression | ISO | RGD:1304918 | 6480464 | Phenobarbital results in increased expression of ASF1B mRNA | CTD | PMID:12832660 |
| phenobarbital | increases expression | ISO | RGD:1312635 | 6480464 | Phenobarbital results in increased expression of ASF1B mRNA | CTD | PMID:20403969 PMID:19482888 |
| pirinixic acid | multiple interactions | ISO | RGD:1312635 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of ASF1B mRNA] | CTD | PMID:17950772 |
| pirinixic acid | increases expression | ISO | RGD:1312635 | 6480464 | pirinixic acid results in increased expression of ASF1B mRNA | CTD | PMID:18301758 PMID:17950772 |
| pirinixic acid | increases expression | ISO | RGD:1304918 | 6480464 | pirinixic acid results in increased expression of ASF1B mRNA | CTD | PMID:12832660 PMID:19162173 |
| pirinixic acid | increases expression | ISO | RGD:1312635 | 6480464 | pirinixic acid results in increased expression of ASF1B mRNA | CTD | PMID:17950772 PMID:18301758 |
| pirinixic acid | increases expression | ISO | RGD:1304918 | 6480464 | pirinixic acid results in increased expression of ASF1B mRNA | CTD | PMID:19162173 PMID:12832660 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:1312635 | 6480464 | Pregnenolone Carbonitrile results in increased expression of ASF1B mRNA | CTD | PMID:22698814 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of ASF1B mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of ASF1B mRNA | CTD | PMID:19167446 |
| sodium dichromate | affects expression | ISO | RGD:1304918 | 6480464 | sodium bichromate affects the expression of ASF1B mRNA | CTD | PMID:22110744 |
| tamoxifen | affects expression | ISO | RGD:1312635 | 6480464 | Tamoxifen affects the expression of ASF1B mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of ASF1B mRNA | CTD | PMID:15336504 |
| testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of ASF1B mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of ASF1B mRNA | CTD | PMID:21592394 |
| tetrachloromethane | increases expression | ISO | RGD:1312635 | 6480464 | Carbon Tetrachloride results in increased expression of ASF1B mRNA | CTD | PMID:17484886 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of ASF1B mRNA | CTD | PMID:19167446 |
| trimellitic anhydride | increases expression | ISO | RGD:1312635 | 6480464 | trimellitic anhydride results in increased expression of ASF1B mRNA | CTD | PMID:19042947 |
| valproic acid | decreases expression | ISO | RGD:1312635 | 6480464 | Valproic Acid results in decreased expression of ASF1B mRNA | CTD | PMID:21427059 |
| valproic acid | increases expression | ISO | RGD:1312635 | 6480464 | Valproic Acid results in increased expression of ASF1B mRNA | CTD | PMID:21427059 |
| valproic acid | increases expression | ISO | RGD:1312635 | 6480464 | Valproic Acid results in increased expression of ASF1B mRNA | CTD | PMID:21427059 PMID:19136453 |
| valproic acid | increases expression | ISO | RGD:1312635 | 6480464 | Valproic Acid results in increased expression of ASF1B mRNA | CTD | PMID:19136453 PMID:21427059 |